| Literature DB >> 35540992 |
Chuanxin Liu1, Xue Sheng1, Yuming Wang1, Jia Yin1, Wei Huang1, Yunshuang Fan2,3, Yubo Li1, Yanjun Zhang4.
Abstract
Steroid hormones are crucial substances that mediate a wide range of vital physiological functions. Because of the important biological significance of steroids, this paper presents a new targeted metabolic method based on adding stable isotope tags to hydroxyl containing and carbonyl containing steroid hormones with two pairs of synthesized derivatization reagents: deuterium 4-(dimethylamino)-benzoic acid (D4-DMBA), and D5-Girard P (D5-GP) using of ultra performance liquid chromatography-multiple reaction monitoring (UPLC-MRM). Firstly, an Oasis PRiME hydrophilic-lipophilic balance (HLB) 96-well solid phase extraction plate was used to pretreat a number of biological samples simultaneously. Secondly, hydroxyl and carbonyl steroids were labeled using two pairs of synthetic reagents, namely DMBA and D4-DMBA, and GP and D5-GP, respectively. Thirdly, the mixed products were detected using UPLC-MRM and the mass spectroscopy conditions were optimized. Methodology development showed that the sensitivity was enhanced 1 to >500-fold. Finally, the new method was applied to analysis of urine samples of healthy males, females and rats. The results revealed that the method can be sensitive and reliable for simultaneous quantification of steroid hormones containing hydroxyl and carbonyl groups in 12 min in a single run. This method provided a powerful tool for studying the metabolic mechanism of steroids and contributed to the development of targeted metabolomics. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35540992 PMCID: PMC9080693 DOI: 10.1039/c8ra01372a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 3.361
Fig. 1All 22 steroid hormone structures and their related metabolic pathways.
Fig. 2Reaction schemes for synthesis of the stable isotope-labeling reagent (A) D5-GP and (B) D4-DMBA.
Fig. 3The derivatization scheme involved in this paper: (A) steroid hormones containing hydroxyl groups derivatized by DMBA; (B) steroid hormones containing carbonyl groups derivatized by GP; (C) steroid hormones containing hydroxyl groups derivatized by D4-DMBA; and (D) steroid hormones containing carbonyl groups derivatized by D5-GP.
Mass spectrometry information and conditions of deuterium derivatization substances
| RT | Substance | Derivatization reagent | Precursor ion | Product ion | Dwell time (ms) | Collision energy (eV) | Cone voltage (V) |
|---|---|---|---|---|---|---|---|
| 2.65 | Cortisone | D5-GP | 499.10 | 85.10 | 0.008 | 30 | 70 |
| 3.25 | 11β,17α,21-Trihydroxy-5β-pregnane-3,20-dione | D5-GP | 503.20 | 85.00 | 0.008 | 30 | 74 |
| 3.20 | 17αOH-PREG | D5-GP | 471.20 | 85.10 | 0.008 | 30 | 72 |
| 3.38 | E3 | D5-GP | 409.10 | 157.00 | 0.008 | 30 | 62 |
| 3.58 | THB | D5-GP | 489.20 | 113.00 | 0.008 | 48 | 80 |
| 3.71 | 11β-Hydroxyandrost-4-ene-3,17-dione | D5-GP | 441.20 | 357.23 | 0.008 | 24 | 60 |
| 3.75 | TES | D5-GP | 427.30 | 343.30 | 0.008 | 28 | 58 |
| 3.75 | DHEA | D5-GP | 427.20 | 80.0 | 0.008 | 26 | 58 |
| 4.04 | 11-Deoxycorticosterone | D5-GP | 469.26 | 385.37 | 0.008 | 28 | 64 |
| 4.79 | PREG | D5-GP | 455.20 | 97.10 | 0.012 | 50 | 68 |
| 6.10 | 5β-Pregnane-3,20-dione | D5-GP | 455.20 | 85.10 | 0.012 | 32 | 66 |
| 4.97 | Androsterone | D5-GP | 429.20 | 255.30 | 0.012 | 34 | 60 |
| 5.87 | PROG | D5-GP | 453.20 | 369.30 | 0.012 | 28 | 58 |
| 4.69 | Cortol | D4-DMBA | 520.20 | 152.10 | 0.012 | 24 | 20 |
| 9.49 | E2 | D4-DMBA | 440.10 | 152.10 | 0.008 | 20 | 44 |
| 4.58 | Tetrahydrocortisol | D4-DMBA | 518.20 | 152.10 | 0.008 | 18 | 24 |
| 4.66 | 19-Hydroxyandrostenedione | D4-DMBA | 454.10 | 152.10 | 0.008 | 22 | 30 |
| 5.25 | 17αOH-PROG | D4-DMBA | 482.10 | 152.00 | 0.008 | 10 | 14 |
| 5.54 | Corticosterone | D4-DMBA | 498.20 | 152.10 | 0.008 | 26 | 52 |
| 6.53 | E1 | D4-DMBA | 424.20 | 152.10 | 0.008 | 16 | 34 |
| 6.55 | 2-Methoxyestrone | D4-DMBA | 452.20 | 152.10 | 0.008 | 16 | 36 |
| 8.46 | Pregnanediol | D4-DMBA | 472.20 | 170.10 | 0.008 | 36 | 48 |
Fig. 4Both D5-Girard P and D4-DMBA chemical synthesis and characterization. (A) showed the successful synthesis of D5-Girard P by 1H-NMR (400 MHz-D2O); (B) showed the characterization of D5-Girard P by means of LC-MS (ES-API, Pos); (C) showed the successful synthesis of D4-DMBA by 1H-NMR (400 MHz-DMSO-d6); and (D) showed the characterization of D4-DMBA by means of LC-MS (ES-API, Pos).
Lower limit of detection (LLOD), LLOQ, linear range, regression coefficient and stability for methodology developmenta
| Steroid hormones | Derivatization reagent | LLOD (pg mL−1) | LLOQ (pg mL−1) | Linear range (pg mL−1) | Regression coefficient ( | Stability within 24 h RSD (%) |
|---|---|---|---|---|---|---|
| 17αOH-PROG | DMBA | 2 | 5 | 5–20 000 | 0.7944 | 1.3 |
| E1 | DMBA | 5 | 10 | 10–20 000 | 0.9822 | 3.2 |
| 2-Methoxyestrone | DMBA | 2 | 20 | 20–20 000 | 0.9881 | 6.2 |
| Tetrahydrocortisol | DMBA | 5 | 50 | 50–20 000 | 0.9942 | 3.1 |
| Corticosterone | DMBA | 20 | 50 | 50–20 000 | 0.9820 | 12 |
| E2 | DMBA | 10 | 20 | 20–20 000 | 0.9941 | 15 |
| Pregnandiol | DMBA | 20 | 50 | 50–20 000 | 0.9911 | 3.4 |
| 19-Hydroxyandrostenedione | DMBA | 50 | 200 | 100–40 000 | 0.9915 | ND |
| Cortol | DMBA | 100 | 200 | 200–40 000 | 0.9709 | 1.0 |
| Androsterone | GP | <2 | 5 | 5–20 000 | 0.9999 | 2.5 |
| 11-Deoxycorticosterone | GP | 2 | 5 | 5–20 000 | 0.9979 | 5.3 |
| THB | GP | 2 | 5 | 5–20 000 | 0.9991 | 8.8 |
| 5β-Pregnane-3,20-dione | GP | 2 | 5 | 5–20 000 | 0.9984 | 1.4 |
| PREG | GP | 2 | 5 | 5–20 000 | 0.9981 | ND |
| E3 | GP | 5 | 10 | 10–20 000 | 0.9997 | 7.2 |
| TES | GP | 2 | 10 | 10–20 000 | 0.9994 | 6.9 |
| 17αOH-PREG | GP | 5 | 10 | 10–20 000 | 0.9993 | 1.5 |
| DHEA | GP | 5 | 20 | 20–20 000 | 0.9999 | 12 |
| Cortisone | GP | 20 | 50 | 50–40 000 | 0.9909 | 2.0 |
| 11β,17α,21-Trihydroxy-5β-pregnane-3,20-dione | GP | 500 | 1000 | 1000–40 000 | 0.9967 | ND |
| PROG | GP | 2500 | 5000 | 5000–40 000 | 0.9986 | ND |
ND: not detected.
Recovery, inter-day precision and intra-day precision for methodology developmenta
| Steroid hormones | Derivatization reagent | Recovery | Inter-day precision | Intra-day precision | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LC (pg mL−1) | (%) | MC (pg mL−1) | (%) | HC (pg mL−1) | (%) | LC (pg mL−) | RSD (%) | MC (pg mL−1) | RSD (%) | HC (pg mL−1) | RSD (%) | LC (pg mL−1) | RSD (%) | MC (pg mL−1) | RSD (%) | HC (pg mL−1) | RSD (%) | |||||||||
| 17αOH-PROG | DMBA | 10 | 96.3 | 500 | 112 | 10 000 | 94.8 | 10 | 3.9 | 500 | 6.3 | 10 000 | 14 | 10 | 3.7 | 500 | 8.4 | 10 000 | 11 | |||||||
| E1 | DMBA | 50 | 117 | 500 | 81.2 | 10 000 | 81.2 | 50 | 2.2 | 500 | 1.3 | 10 000 | 9.0 | 50 | 10 | 500 | 1.2 | 10 000 | 11 | |||||||
| 2-Methoxyestrone | DMBA | 50 | 88.9 | 500 | 80.6 | 10 000 | 113 | 50 | 1.3 | 500 | 7.9 | 10 000 | 14 | 50 | 1.4 | 500 | 6.5 | 10 000 | 13 | |||||||
| Tetrahydrocortisol | DMBA | 50 | 101 | 500 | 80.8 | 10 000 | 88.1 | 50 | 4.6 | 500 | 8.4 | 10 000 | 3.1 | 50 | 3.7 | 500 | 12 | 10 000 | 3.2 | |||||||
| Corticosterone | DMBA | 50 | 101 | 500 | 79.2 | 10 000 | 107 | 50 | 1.8 | 500 | 11 | 10 000 | 12 | 50 | 2.7 | 500 | 7.4 | 10 000 | 11 | |||||||
| E2 | DMBA | 50 | 123 | 500 | 87.2 | 10 000 | 107 | 50 | 0.9 | 500 | 9.0 | 10 000 | 6.5 | 50 | 1.8 | 500 | 7.9 | 10 000 | 6.5 | |||||||
| Pregnandiol | DMBA | 50 | 108 | 500 | 84.1 | 10 000 | 121 | 50 | 3.2 | 500 | 7.2 | 10 000 | 5.1 | 50 | 5.1 | 500 | 13 | 10 000 | 6.4 | |||||||
| 19-Hydroxyandrostenedione | DMBA | 500 | ND | 10 000 | ND | 40 000 | ND | 500 | 5.7 | 10 000 | 13 | 40 000 | 7.9 | 500 | 7.1 | 10 000 | 14 | 40 000 | 6.0 | |||||||
| Cortol | DMBA | 500 | 91.2 | 10 000 | 95.0 | 40 000 | 70.2 | 500 | 1.3 | 10 000 | 3.1 | 40 000 | 2.7 | 500 | 1.7 | 10 000 | 15 | 40 000 | 2.8 | |||||||
| Androsterone | GP | 10 | 80.1 | 500 | 85.2 | 10 000 | 102 | 10 | 3.9 | 500 | 2.3 | 10 000 | 4.6 | 10 | 5.7 | 500 | 2.0 | 10 000 | 3.5 | |||||||
| 11-Deoxycorticosterone | GP | 10 | 77.1 | 500 | 98.1 | 10 000 | 120 | 10 | 11.3 | 500 | 2.7 | 10 000 | 0.9 | 10 | 12 | 500 | 5.4 | 10 000 | 7.1 | |||||||
| THB | GP | 10 | 96.7 | 500 | 82.6 | 10 000 | 91.0 | 10 | 4.9 | 500 | 7.7 | 10 000 | 4.0 | 10 | 4.2 | 500 | 6.7 | 10 000 | 4.1 | |||||||
| 5β-Pregnane-3,20-dione | GP | 10 | 101 | 500 | 83.2 | 10 000 | 93.5 | 10 | 1.3 | 500 | 3.6 | 10 000 | 3.1 | 10 | 1.5 | 500 | 4.1 | 10 000 | 3.5 | |||||||
| PREG | GP | 10 | 82.0 | 500 | 77.5 | 10 000 | 91.4 | 10 | 3.2 | 500 | 1.0 | 10 000 | 1.5 | 10 | 2.9 | 500 | 7.5 | 10 000 | 3.0 | |||||||
| E3 | GP | 50 | 84.7 | 500 | 80.5 | 10 000 | 109 | 50 | 3.7 | 500 | 11 | 10 000 | 6.2 | 50 | 4.2 | 500 | 8.9 | 10 000 | 10 | |||||||
| TES | GP | 50 | 91.5 | 500 | 102 | 10 000 | 89.7 | 50 | 6.1 | 500 | 1.2 | 10 000 | 4.7 | 50 | 2.5 | 500 | 1.3 | 10 000 | 2.8 | |||||||
| 17αOH-PREG | GP | 50 | 86.5 | 500 | 100 | 10 000 | 75.0 | 50 | 2.3 | 500 | 9.3 | 10 000 | 2.4 | 50 | 5.2 | 500 | 8.5 | 10 000 | 9.1 | |||||||
| DHEA | GP | 50 | 99.4 | 500 | 105 | 10 000 | 96.7 | 50 | 1.9 | 500 | 1.8 | 10 000 | 3.4 | 50 | 1.6 | 500 | 2.5 | 10 000 | 2.1 | |||||||
| Cortisone | GP | 50 | 84.1 | 500 | 94.6 | 40 000 | 104 | 50 | 8.5 | 500 | 4.7 | 40 000 | 1 | 50 | 5.6 | 500 | 9.2 | 40 000 | 1.1 | |||||||
| 11β,17α,21-Trihydroxy-5β-pregnane-3,20-dione | GP | 2000 | 88.2 | 10 000 | 84.8 | 40 000 | 85 | 2000 | 4.1 | 10 000 | 3.0 | 40 000 | 8.7 | 2000 | 4.3 | 10 000 | 6.6 | 40 000 | 12 | |||||||
| PROG | GP | 5000 | 82.3 | 10 000 | 120 | 40 000 | 94 | 5000 | 1.3 | 10 000 | 1.5 | 40 000 | 1.9 | 5000 | 11 | 10 000 | 3.0 | 40 000 | 2.5 | |||||||
LC: low concentration. MC: medium concentration. HC: high concentration. ND: not detected.
Fig. 5Peaks of quantification based on D/H stable isotope DMBA and GP labeling: extracted ion chromatogram of heavy and light labeled substances.
Steroid levels in urine of healthy adult males, females and ratsa
| Substance | Derivatization reagent | Average content of urine samples in female (pg mL−1) | Average content of urine samples in male (pg mL−1) | Average content of urine samples in male rats (pg mL−1) | ||
|---|---|---|---|---|---|---|
| This study | Reference [ | This study | Reference [ | |||
| Cortol | DMBA | 1326 | — | 13 340 | — | ND |
| E2 | DMBA | 216.1 | 366 | 46.14 | 34 | 25.22 |
| Tetrahydrocortisol | DMBA | 884.1 | 902 | 3166 | 2588 | 2812 |
| Corticosterone | DMBA | 122.8 | 466 | 396.4 | 1013 | ND |
| E1 | DMBA | 52.89 | 41 | 12.15 | 20 | 14.54 |
| 2-Methoxyestrone | DMBA | 74.95 | — | 37.88 | — | 84.00 |
| Cortisone | GP | 38 766 | — | 23 479 | — | ND |
| 17αOH-PREG | GP | 3343 | 508 | ND | ND | ND |
| E3 | GP | 188.1 | 877 | 51.04 | 242 | ND |
| THB | GP | 228.3 | — | 244.9 | — | ND |
| TES | GP | 4234 | 16 626 | 15 988 | 17 884 | 16.68 |
| DHEA | GP | 1989 | 5329 | 5089 | 6851 | 1602 |
| 11-Deoxycorticosterone | GP | 43.41 | ND | 34.13 | 35 | ND |
| PREG | GP | 75.74 | ND | ND | ND | ND |
| 5β-Pregnane-3,20-dione | GP | 262.8 | — | ND | — | ND |
| Androsterone | GP | 1145 | 3529 | 2773 | 5999 | 312.9 |
ND: not detected. —: relevant data not found.